4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vivos Therapeutics, Inc. (VVOS) operates in the Medical Devices industry and is headquartered in Littleton, United States with about 270 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, VVOS reported $17M in revenue and ($21M) in net income.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Interactive charts & full statements → Open the VVOS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $17M | $15M | $14M | $16M | — |
| Gross Profit | $10M | $9M | $8M | $10M | — |
| Operating Income (EBIT) | ($20M) | ($11M) | ($17M) | ($25M) | — |
| Net Income | ($21M) | ($11M) | ($14M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $5M | $4M | $7M | $4M | $3M |
| Gross Profit | $3M | $3M | $4M | $2M | $2M |
| Operating Income (EBIT) | ($7M) | ($6M) | ($5M) | ($5M) | ($4M) |
| Net Income | ($8M) | ($7M) | ($5M) | ($5M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $25M | $15M | $11M | $14M | — |
| Total Liabilities | $27M | $7M | $10M | $9M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VVOS viewer.
About TickerBase · Data methodology & sources